Search Within

Guilherme Harada

  1. "Elsevier Inc."
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. GME, Medicine (6)
  2. Graduate Medical Education (6)
  3. Department of Medicine (5)
  4. Solid Tumor Oncology Division (5)
  5. Thoracic Oncology (5)
  6. Clinical Pharmacy Specialists (3)

More Groups

People
  1. Alexander Drilon (5)
  2. Christina Falcon (3)
  3. Clare Wilhelm (3)
  4. Dazhi Liu (3)
  5. Monica Chen (3)
  6. Mark Kris (2)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (3)
Publications
  1. Journal of Thoracic Oncology (5)
  2. Cancer Genetics (1)
Publishers
  1. Elsevier Inc. (6)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brief report: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to “false” decreases in renal function
    Journal Article

    Chen, M. F.; Harada, G.; Liu, D.; DeMatteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A.; Gutgarts, V.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Beware: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to "False" decreases in renal function
    Meeting Abstract

    Chen, M.; Harada, G.; Liu, D.; Dematteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Activating MET tyrosine kinase domain mutations as de novo oncogenic drivers in non-small cell lung cancer
    Meeting Abstract

    Nakazawa, S.; Pecci, F.; Ricciuti, B.; Harada, G.; Lee, J. K.; Alessi, J. V.; Barrichello, A. P. C.; Vaz, V. R.; Lamberti, G.; Di Federico, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • EGFR tyrosine kinase inhibitors and combination strategies in first-line treatment of advanced NSCLC: A network meta-analysis
    Meeting Abstract

    de Castro, G.; Stock, G. T.; Harada, G.; Pereira, A. A. L.; Sadeghirad, B.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Brief Report: Chylothorax and chylous ascites during RET tyrosine kinase inhibitor therapy
    Journal Article

    Kalchiem-Dekel, O.; Falcon, C. J.; Bestvina, C. M.; Liu, D.; Kaplanis, L. A.; Wilhelm, C.; Eichholz, J.; Harada, G.; Wirth, L. J.; Digumarthy, S. R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults
    Journal Article

    Harada, G.; Drilon, A.
    Cancer Genetics (2022)

    Fulltext@MSK | Save